News

Oct 25, 2017
Professor Schilsky presenting preliminary Phase 2 data with WTX101
Read more

Oct 24, 2017
Wilson Therapeutics reached agreement with FDA and EMA to start Phase 3 study
Read more

May 18, 2017
Jonas Hansson interviewed by Analysguiden
Read more

Apr 27, 2017
Wilson Therapeutics at Redeye
Read more

Apr 24, 2017
Interview with CEO Jonas Hansson
Read more